Viral hepatitis: Past, present, and future

Each hepatitis virus-Hepatitis A, B, C, D, E, and G-poses a distinct scenario to the patient and clinician alike. Since the discovery of each virus, extensive knowledge regarding epidemiology, virologic properties, and the natural clinical and immunologic history of acute and chronic infections has been generated. Basic discoveries about host immunologic responses to acute and chronic viral infections, combined with virologic data, has led to vaccines to prevent Hepatitis A, B, and E and highly efficacious antivirals for Hepatitis B and C. These therapeutic breakthroughs are transforming the fields of hepatology, transplant medicine in general, and public and global health. Most notably, there is even an ambitious global effort to eliminate chronic viral hepatitis within the next decade. While attainable, there are many barriers to this goal that are being actively investigated in basic and clinical labs on the local, national, and international scales. Herein, we discuss pertinent clinical information and recent organizational guidelines for each of the individual hepatitis viruses while also synthesizing this information with the latest research to focus on exciting future directions for each virus.

Keywords: Hepatitis A; Hepatitis B; Hepatitis C; Hepatitis D; Hepatitis E; Hepatitis G; Viral Hepatitis.

©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.

Conflict of interest statement

Conflict-of-interest statement: The authors have no conflicts of interest to declare.

Similar articles

Raney AK, Hamatake RK, Hong Z. Raney AK, et al. Expert Opin Investig Drugs. 2004 Mar;13(3):289-93. doi: 10.1517/13543784.13.3.289. Expert Opin Investig Drugs. 2004. PMID: 15013947

Nagra N, Kozarek RA, Burman BE. Nagra N, et al. Adv Ther. 2022 Apr;39(4):1524-1552. doi: 10.1007/s12325-022-02070-z. Epub 2022 Feb 27. Adv Ther. 2022. PMID: 35220557 Review.

Terrault NA, Levy MT, Cheung KW, Jourdain G. Terrault NA, et al. Nat Rev Gastroenterol Hepatol. 2021 Feb;18(2):117-130. doi: 10.1038/s41575-020-00361-w. Epub 2020 Oct 12. Nat Rev Gastroenterol Hepatol. 2021. PMID: 33046891 Review.

Dunn R, Wetten A, McPherson S, Donnelly MC. Dunn R, et al. World J Gastroenterol. 2022 Jan 7;28(1):76-95. doi: 10.3748/wjg.v28.i1.76. World J Gastroenterol. 2022. PMID: 35125820 Free PMC article. Review.

Jonas MM. Jonas MM. Clin Liver Dis. 2000 Nov;4(4):849-77. doi: 10.1016/s1089-3261(05)70145-8. Clin Liver Dis. 2000. PMID: 11232361 Review.

Cited by

Şen İ, Dumlu Ş. Şen İ, et al. Turk J Gastroenterol. 2024 Jul;35(7):568-576. doi: 10.5152/tjg.2024.23444. Turk J Gastroenterol. 2024. PMID: 39128054 Free PMC article.

Chen J, Wu L, Li Y. Chen J, et al. Biomark Res. 2024 May 31;12(1):53. doi: 10.1186/s40364-024-00601-0. Biomark Res. 2024. PMID: 38816776 Free PMC article. Review.

Hu Y, Geng Q, Wang L, Wang Y, Huang C, Fan Z, Kong D. Hu Y, et al. J Mol Med (Berl). 2024 Jul;102(7):859-874. doi: 10.1007/s00109-024-02455-3. Epub 2024 May 28. J Mol Med (Berl). 2024. PMID: 38802517 Free PMC article. Review.

Karpov DS. Karpov DS. Int J Mol Sci. 2024 May 13;25(10):5292. doi: 10.3390/ijms25105292. Int J Mol Sci. 2024. PMID: 38791336 Free PMC article.

Mooney AH, Draper SL, Burn OK, Anderson RJ, Compton BJ, Tang C, Farrand KJ, Di Lucia P, Ravà M, Fumagalli V, Giustini L, Bono E, Godfrey DI, Heath WR, Yuan W, Chisari FV, Guidotti LG, Iannacone M, Sidney J, Sette A, Gulab SA, Painter GF, Hermans IF. Mooney AH, et al. JHEP Rep. 2024 Feb 12;6(5):101038. doi: 10.1016/j.jhepr.2024.101038. eCollection 2024 May. JHEP Rep. 2024. PMID: 38694959 Free PMC article.

References

    1. Coulepis AG, Locarnini SA, Westaway EG, Tannock GA, Gust ID. Biophysical and biochemical characterization of hepatitis A virus. Intervirology. 1982;18:107–127. - PubMed
    1. Coulepis AG, Anderson BN, Gust ID. Hepatitis A. Adv Virus Res. 1987;32:129–169. - PubMed
    1. Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine. 2010;28:6653–6657. - PubMed
    1. Rezende G, Roque-Afonso AM, Samuel D, Gigou M, Nicand E, Ferre V, Dussaix E, Bismuth H, Féray C. Viral and clinical factors associated with the fulminant course of hepatitis A infection. Hepatology. 2003;38:613–618. - PubMed
    1. Cuthbert JA. Hepatitis A: old and new. Clin Microbiol Rev. 2001;14:38–58. - PMC - PubMed